Cancer

Events

Partner Content

4th RAS-Targeted Drug Development Summit

For decades, RAS has existed as an elusive therapeutic target, and drugging this high-value oncogene was deemed impossible.

Events

Partner Content

Targeted Radiopharmaceuticals Summit US (TRP US)

The inaugural Targeted Radiopharmaceuticals Summit US will bring together a worldwide community of specialists to address long-standing challenges in radiopharmac

Events

Advancing Engineered, Native & Bispecific TCRs to Effectively Treat Solid Tumors

Partner Content

TCR-based Therapeutics for Solid Tumors Summit

Hear from experts at the TCR based Therapeutics Summit

Events

Partner Content

Welcome to the 2nd Tumor Myeloid-Directed Therapies Summit

Identify, Validate, & Clinically Develop Novel Targets to Modulate Myeloid Cells & Overcome Solid Tumor Barriers

News

Biliary tract cancer drug granted orphan drug designation in...

The US regulator has granted biliary tract cancer therapy Silmitasertib orphan drug designation.

News

Sugemalimab plus chemo boosts lung cancer survival, trial re...

Lung cancer drug sugemalimab has delivered positive results following a phase 3 trial.

4th RAS-Targeted Drug Development Summit

Targeted Radiopharmaceuticals Summit US (TRP US)

TCR-based Therapeutics for Solid Tumors Summit

Welcome to the 2nd Tumor Myeloid-Directed Therapies Summit

Biliary tract cancer drug granted orphan drug designation in...

Sugemalimab plus chemo boosts lung cancer survival, trial re...

Novo sues Lilly over 'misleading' GLP-1 ad campaigning

Discover a new era of healthcare panel engagement: Grounded ...

Cancer

Editor's Picks